Navigation Links
OAsys Carticare

ProductsOAsys Carticare
Company Innovation Sports
Item OAsys Carticare
Features 
  • New Accutrac™ ROM hinges with easy-to-use flexion/extension stops - Lockout: 0°// Flexion: 45°,60°,75°,90°// Extension: 10°,20°,30°,40°- Optional Lockout Kit // Lockout: 10°,20°,30°// Flexion: 10°,20°,30°
  • Acculign™ slide bar for on-the-sport medial or lateral unloading
  • Heat-moldable frame for customized fitting by O&P professionals [call for heating instructions]
  • Quick-release buckles and 4-strap design for easy application and removal
  • 30-day, no-risk trial on osteoarthritis applications
  • 1-year limited warranty on frame and hinges
  • Total Support System™ for ACL, MCL, LCL, PCL, rotary and combine instabilities
  • Exclusive Gel Fit™ condylar pads provide ultimate joint line comfort and cushion bony prominences for improved patient satisfaction
  • Reduced medial surface area for streamlined fit and improved comfort on fleshy legs
  • Dual-hinge design provides functional support and prevents brace from rotating on the leg
  • Non-corrosive materials, ideal for water sports
  • Pivoting, quick-release buckles enable proper strap placement
    • Description OAsys CartiCare enables unloading of the medial or lateral compartment for relief of pain associated with unicompartmental osteoarthritis. Plus, we equipped this unique brace with our new Accutrac™ ROM hinge, making it further suitable for post-op and long-term rehab [>4weeks] protocols requiring unloading and/or adjustable flexion/extension control.

    Indications:
  • Medial or lateral compartment unloading for unicompartmental OA or articular cartilage healing
  • Post-op, rehab and functional support plus unloading for protocols requiring reduced medial or lateral joint loads during recovery
  • Functional support for patients with varus or valgus alignment
  • Multi-dimensional support for ACL, MCL, LCL, PCL, rotary and combined instabilities
  • Non and low contact/impact activities
    • Info Innovation Sports
    Customer Service: (800) 222-4284
    Web site: http://www.isports.com/

    Related medicine products :

    1. Adjustable Trial Frame - Adult
    2. Adjustable Trial Frame - Child
    3. Sophy Adjustable Pressure Valves
    4. Adjustable Troutman Trephine Handle, Fits 7mm - 9mm trephines
    5. Adjustable Troutman Trephine Handle, Fits 5mm - 7mm trephines
    6. Adjustable Troutman Trephine Handle, Fits 9mm -11mm trephines
    7. MSV-10 Adjustable Velcro
    8. Adjustable Distal Radius Fixator
    9. Adjustable Large Fixator
    10. Velcro Adjustable
    11. Adjustable Leg Support Stand
    ...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
    ...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
    ...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
    ...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
    Medicine Products:
    (Date:8/7/2008)...- Testing men for elevated levels of prostate-spec...rd screening test for prostate cancer -- may be bi...e deceptively low. And this bias may be creating ...ying diagnosis, according to a new study led by in...rham Veterans Affairs (VA) Medical Center. , "W...
    (Date:8/7/2008)...oesn,t require fasting, could ID millions who don,...Aug. 7 (HealthDay News) -- A widely used test to m...could help identify millions of people with undete...released by a team of experts. , The hemoglobi...d cells have been exposed to in the previous 120 d...
    (Date:8/7/2008)..., Md., Aug. 7 /PRNewswire-USNewswire/ -- Vapotherm...oducts, has received 510(k),clearance from the Foo...(TM), the first high flow humidification system to...cation technology into one device for,the optimal ...her Vapotherm products are currently used in neona...
    (Date:8/7/2008)...rves Beneficiary Access to High Quality Nursing Ho... Staffing Efforts, JOPLIN, Mo., Aug. 7 /PRNewswir... protecting the nation,s critical frontline-caregi...r Care (CPSC) today thanked,Senator Pat Roberts fo...in,Congress to stop the Bush Administration from m...
    Breaking Medicine News(10 mins):Health News:PSA screening may be biased against obese men, leading to more aggressive cancers 2Health News:Blood Sugar Test May Also Aid Diabetes Detection 2Health News:Vapotherm(R) Precision Flow(TM) Receives FDA 510(k) Clearance 2Health News:Senator Pat Roberts Praised for Leading Successful Effort to Derail $6.2 Million Kansas Medicare Cuts 2
    ...up a task force to fill up the healthcare sector, ...hnicians. The recruitment not only fills // up the...ed. The move is based on the recommendations of a...mission on Macroeconomics and Health, highlighting...
    ...ves of two children in Mumbai and many more with t...rious hospitals. // Health authorities said that m... those 90-odd people who are undergoing treatment....itals Wednesday, particularly in south Mumbai, whe...
    ...hat decrease in the fine particulate air pollution.... This drop in mortality rates was specifically ob...ase, according to Dr. Francine Laden, from Harvard...n a statement. Several epidemiologic studies have ...
    ...n the opinion of parents’ when compared to rugby-c...esearch has pointed out that Australian Football a...l other types of football. // The Aussie code see...juries, the second place being occupied by league ...
    Other Medicine News:
    (Date:8/6/2008)...g. 6 /PRNewswire-USNewswire/ -- Here are highlight...lthSource. You may cite,this publication as often ...ibution is required. Reprinting is allowed for a f... as your editorial policies permit: Visit, http://...r subscription,information, 800-876-8633, extensio...
    (Date:8/6/2008)... /- In the most recent issue of,Optom...shed by German,scientist and researcher, Dr. Burkh... with vision problems have a hard time learning ba...e vision therapy is given,math skills improve., ...rman television news,programs which reported on hi...
    (Date:8/5/2008)...g. 5 /- Rib-X Pharmaceuticals, Inc.,(...pany focused on the,discovery and development of n...esistant infections, announced today that company,...two conferences this,week., Gordon Research Confe...Bhattacharjee, Ph.D, Senior Scientist, presented a...
    (Date:8/5/2008)...to help heart failure patients survive until,trans...d damage than,earlier heart devices, ANN ARBOR, M...annon,made history on July 30. That,s when he beca...e a new type of experimental and very high-tech,he...anted in his chest, and,connected to his failing h...
    Breaking Medicine Technology:August 2008 Mayo Clinic Women's HealthSource Highlights Avoiding Blood Pressure Increase at Menopause, Healthful Benefits of Dark Chocolate and Scheduling a Colorectal Exam 2August 2008 Mayo Clinic Women's HealthSource Highlights Avoiding Blood Pressure Increase at Menopause, Healthful Benefits of Dark Chocolate and Scheduling a Colorectal Exam 3August 2008 Mayo Clinic Women's HealthSource Highlights Avoiding Blood Pressure Increase at Menopause, Healthful Benefits of Dark Chocolate and Scheduling a Colorectal Exam 4Vision Problems Affect How Children Learn Math Skills 2Rib-X Pharmaceuticals, Inc. Announces Recent and Upcoming Presentations at Scientific Conferences 2Rib-X Pharmaceuticals, Inc. Announces Recent and Upcoming Presentations at Scientific Conferences 3First U.S. Patient to Receive New Heart-Assist Device Doing Well After Surgery at University of Michigan 2First U.S. Patient to Receive New Heart-Assist Device Doing Well After Surgery at University of Michigan 3First U.S. Patient to Receive New Heart-Assist Device Doing Well After Surgery at University of Michigan 4Calling for More Veterinarians 10104 1Calling for More Veterinarians 10104 2MiddleBrook Pharmaceuticals to Raise 2421 Million Through Private Placement of Common Equity 10102 1MiddleBrook Pharmaceuticals to Raise 2421 Million Through Private Placement of Common Equity 10102 2MiddleBrook Pharmaceuticals to Raise 2421 Million Through Private Placement of Common Equity 10102 3MiddleBrook Pharmaceuticals to Raise 2421 Million Through Private Placement of Common Equity 10102 4Kensey Nash Reports Second Quarter EPS of 240 21 and Revenue of 2419 6 Million 10099 1Kensey Nash Reports Second Quarter EPS of 240 21 and Revenue of 2419 6 Million 10099 2Kensey Nash Reports Second Quarter EPS of 240 21 and Revenue of 2419 6 Million 10099 3Kensey Nash Reports Second Quarter EPS of 240 21 and Revenue of 2419 6 Million 10099 4Kensey Nash Reports Second Quarter EPS of 240 21 and Revenue of 2419 6 Million 10099 5Kensey Nash Reports Second Quarter EPS of 240 21 and Revenue of 2419 6 Million 10099 6Kensey Nash Reports Second Quarter EPS of 240 21 and Revenue of 2419 6 Million 10099 7Kensey Nash Reports Second Quarter EPS of 240 21 and Revenue of 2419 6 Million 10099 8Kensey Nash Reports Second Quarter EPS of 240 21 and Revenue of 2419 6 Million 10099 9Kensey Nash Reports Second Quarter EPS of 240 21 and Revenue of 2419 6 Million 10099 10Kensey Nash Reports Second Quarter EPS of 240 21 and Revenue of 2419 6 Million 10099 11Kensey Nash Reports Second Quarter EPS of 240 21 and Revenue of 2419 6 Million 10099 12Kensey Nash Reports Second Quarter EPS of 240 21 and Revenue of 2419 6 Million 10099 13Digirad to Introduce New Clinical Standard for Cardiac SPECT 10098 1Digirad to Introduce New Clinical Standard for Cardiac SPECT 10098 2Digirad to Introduce New Clinical Standard for Cardiac SPECT 10098 3
    ....--(BUSINESS WIRE)--Mar 14, 2007 - ArQule, Inc.,(N...iety of,Clinical Oncology (ASCO) has accepted for ...97 (A Phase 1 Dose Escalation Study of,ARQ 197, a ...nts,with Metastatic Solid Tumors) at the 43rd ASCO...presentation will describe findings,from a Phase 1...
    ...CO, March 19, 2007 /PRNewswire-FirstCall/ --,Mediv... from its,randomized, double-blinded, placebo-cont...tients with mild-to-moderate Alzheimer,s,disease d...e,significantly improved compared to patients taki... which assessed cognitive function,memory, abilit...
    Other Medicine Technology:ArQule Announces Acceptance of Clinical Data on ARQ 197, c-Met,Inhibitor, for Oral Presentation at ASCO 2ArQule Announces Acceptance of Clinical Data on ARQ 197, c-Met,Inhibitor, for Oral Presentation at ASCO 3ArQule Announces Acceptance of Clinical Data on ARQ 197, c-Met,Inhibitor, for Oral Presentation at ASCO 4Medivation Announces Presentation of Full Top-Line Data From,Dimebon Six-Month Trial at Major International Alzheimer's Disease,Conference 2Medivation Announces Presentation of Full Top-Line Data From,Dimebon Six-Month Trial at Major International Alzheimer's Disease,Conference 3Medivation Announces Presentation of Full Top-Line Data From,Dimebon Six-Month Trial at Major International Alzheimer's Disease,Conference 4